Rocket Lab’s Double Game: Record Backlog Meets Insider Selling and a Ticking IPO Clock

For Rocket Lab, the coming week is less about a single catalyst and more about how multiple forces collide. An Electron launch for a Japanese radar satellite operator sits on the same calendar as the SpaceX public listing, while insider profit-taking and a brutal 23% weekly selloff have investors recalibrating. The stock closed Friday at $110.08, down 8.23% on the day and 23.28% for the week, but the Year-to-date gain still stands at 44.86%.

The selloff did not erase the longer-term picture. Rocket Lab’s 50-day moving average of $96.14 held, and the 200-day line at $72.63 remains comfortably below. The 14-day relative strength index of 46.6 indicates neutral territory — neither overheated nor oversold. Yet the annualized 30-day volatility of 137% underscores just how aggressively the stock can swing. With the SpaceX IPO penciled in for June 12 under the ticker SPCX at a minimum valuation of $1.8 trillion, the entire commercial space sector is bracing for a valuation test.

An Electron Mission as the Immediate Bellwether

“The Grain Goddess Provides” mission will lift off from Rocket Lab’s Launch Complex 1 in New Zealand, carrying the QPS-SAR-13 (MIKURA-I) radar satellite for Japanese customer iQPS. The target orbit is approximately 575 kilometers at a 42-degree inclination. It would mark the eighth launch for iQPS under a larger agreement covering 15 missions for its synthetic aperture radar constellation.

Rocket Lab has not yet confirmed a precise launch window — the official guidance remains “NET June 2026,” with no specific time given. Every update to that timeline will serve as the next concrete signal for traders. The previous quarterly report landed on May 7; since then, operational tempo has become the dominant narrative.

At the same time, macro data adds another layer of uncertainty. The U.S. Labor Department releases the May CPI on June 10 and the PPI on June 11, just ahead of the Federal Reserve’s June 16-17 meeting with fresh economic projections and interest rate guidance. For a high-growth name like Rocket Lab, any hint on the rate path can ripple immediately into the stock’s risk premium.

Blue Origin’s Explosion and the Sector Shock

The market’s mood soured after Blue Origin’s failed hotfire test of its New Glenn rocket at Cape Canaveral on May 28. The rocket exploded during the test; no satellites or personnel were harmed. But the incident hit space equities broadly the next trading day: Rocket Lab dropped 6%, AST SpaceMobile cratered 17%, and Planet Labs fell 8%. Rocket Lab continued to bleed the rest of the week.

Operationally, the explosion had no direct impact on Rocket Lab. Yet it reminded the market that space technology tolerates little failure, and technical mishaps quickly become valuation risks for the whole segment.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Insider Sales Near the Peak

The selloff coincided with notable insider activity. Director Alexander Slusky sold 60,000 shares on May 28 at prices between $149.10 and $150.00, netting around $9.0 million — near the stock’s then-record high. He added a further 40,000 shares on June 2 at $123.60, bringing the total to 100,000 shares for approximately $13.9 million.

President Marvin Clevenger, COO Frank Klein, and General Counsel Arjun Kampani also trimmed their holdings. All transactions were executed under pre-arranged 10b5-1 plans, which are designed to avoid accusations of opportunistic timing. Still, a cluster of selling near the stock’s peak — especially after explosive gains — can be a sensitive signal for the market.

Defense Dollars and a Growing Backlog

Under the surface, Rocket Lab’s fundamentals tell a different story. The first-quarter results showed a record backlog of $2.2 billion on roughly $200 million in quarterly revenue. Space Systems has surpassed traditional launch as the larger revenue contributor, transforming the company into an integrated space supplier rather than just a rocket operator.

In May, the U.S. Space Force awarded a $90 million contract for Rocket Lab to build and operate two geostationary satellites — marking an entry into the GEO market and deepening defense ties. Even larger is the role with the Space Development Agency: Rocket Lab’s solution for the Tracking Layer Tranche 3 constellation passed its System Requirements Review and now serves as the program’s technical baseline. A $816 million award joins a previous $515 million injection, pushing the total SDA exposure above $1.3 billion.

The Suborbital Test and the IPO Countdown

On June 10, Rocket Lab is scheduled to launch the suborbital “Curveball” mission from Wallops Island, Virginia, under the HASTE program for government and intelligence clients. That launch comes two days before the planned SpaceX IPO.

This combination turns the week into a stress test: operational wins offer a counterweight to near-term market jitters, but the stock’s immediate direction hinges on whether investors accept SpaceX’s valuation. If the IPO opens strongly, it could validate high multiples across commercial space. A weak debut would keep the screws on smaller players.

For now, Rocket Lab’s 27% retreat from its $151.00 52-week high (set on May 27) has created distance from the record, but not from the underlying narrative. The next Electron launch will test execution. The macro data will test patience. And the SpaceX debut will test whether investors still believe the sky is the limit.